We are live on
!
Find out more
EFM
E Fund Management Portfolio holdings
AUM
$3.37B
This Fund
S&P 500
This Quarter
Est. Return
-25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.39B
AUM Growth
–
Cap. Flow
+$2.72B
Cap. Flow
% of AUM
113.56%
Top 10 Holdings %
Top 10 Hldgs %
77.94%
Holding
271
New
271
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.16B |
| 2 |
JD.com
JD
|
+$221M |
| 3 |
Pinduoduo
PDD
|
+$210M |
| 4 |
Baidu
BIDU
|
+$183M |
| 5 |
NetEase
NTES
|
+$122M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 62.14% |
| 2 | Communication Services | 18.47% |
| 3 | Technology | 9.22% |
| 4 | Healthcare | 3.01% |
| 5 | Financials | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Broadridge
BR
$17.2B
| $209K | 0.01% |
+1,252
| New | +$213K |
|
227
Cytokinetics
CYTK
$11B
| $209K | 0.01% |
+5,840
| New | +$172K |
|
228
Deere & Co
DE
$170B
| $208K | 0.01% |
+620
| New | +$223K |
|
229
Arista Networks
ANET
$219B
| $203K | 0.01% |
+9,472
| New | +$217K |
|
230
Qorvo
QRVO
$7.63B
| $203K | 0.01% |
+1,214
| New | +$226K |
|
231
Hewlett Packard
HPE
$63.2B
| $202K | 0.01% |
+14,077
| New | +$203K |
|
232
Prologis
PLD
$138B
| $201K | 0.01% |
+1,599
| New | +$208K |
|
233
Zimmer Biomet
ZBH
$17.7B
| $201K | 0.01% |
+1,410
| New | +$207K |
|
234
Seres Therapeutics
MCRB
$48.1M
| $191K | 0.01% |
+1,375
| New | +$269K |
|
|
CCXI
235
DELISTED
ChemoCentryx, Inc.
CCXI
| $191K | 0.01% |
+11,179
| New | +$174K |
|
236
Ironwood Pharmaceuticals
IRWD
$611M
| $185K | 0.01% |
+14,130
| New | +$183K |
|
237
Acadia Pharmaceuticals
ACAD
$4.25B
| $177K | 0.01% |
+10,673
| New | +$206K |
|
|
CLVS
238
DELISTED
Clovis Oncology, Inc.
CLVS
| $176K | 0.01% |
+39,535
| New | +$190K |
|
239
Ocugen
OCGN
$410M
| $173K | 0.01% |
+24,109
| New | +$177K |
|
240
Opko Health
OPK
$921M
| $170K | 0.01% |
+46,542
| New | +$173K |
|
|
SRNE
241
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $166K | 0.01% |
+21,764
| New | +$185K |
|
242
BioCryst Pharmaceuticals
BCRX
$2.37B
| $163K | 0.01% |
+11,349
| New | +$179K |
|
243
Viatris
VTRS
$20.1B
| $161K | 0.01% |
+11,881
| New | +$169K |
|
244
Heron Therapeutics
HRTX
$86.3M
| $158K | 0.01% |
+14,805
| New | +$180K |
|
|
VXRT
245
DELISTED
Vaxart
VXRT
| $157K | 0.01% |
+19,803
| New | +$163K |
|
246
Curis
CRIS
$9.53M
| $156K | 0.01% |
+50
| New | +$156K |
|
|
GTHX
247
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $156K | 0.01% |
+11,607
| New | +$189K |
|
|
KYNB
248
Kyntra Bio
KYNB
$28.5M
| $155K | 0.01% |
+608
| New | +$215K |
|
249
Inovio Pharmaceuticals
INO
$79.8M
| $155K | 0.01% |
+1,807
| New | +$181K |
|
|
FOLD
250
DELISTED
Amicus Therapeutics
FOLD
| $151K | 0.01% |
+15,771
| New | +$161K |
|
Similar funds
VFCM
DFO
DIA
5NCM
TAM
CS
OAM
QCG
E Fund Management's Q3 2021 Portfolio in Review
Q3 2021 is the first quarter with a 13F filing on record for E Fund Management, which disclosed 271 positions worth $2.39B. Its ten largest holdings account for 78% of the portfolio.
Its largest position is Alibaba: 6,396,735 shares worth $947M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 62% of assets, followed by Communication Services and Technology.
- E Fund Management's largest Q3 2021 buy was Alibaba: 6,396,735 shares worth $947M.
- E Fund Management's ten largest holdings make up 78% of its $2.39B portfolio in Q3 2021.
- E Fund Management disclosed 271 positions in Q3 2021, its first 13F filing on record.
Based on E Fund Management's 13F filing for Q3 2021, filed 12 Nov 2021.